Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
Authors
Keywords
-
Journal
Cells
Volume 8, Issue 11, Pages 1430
Publisher
MDPI AG
Online
2019-11-14
DOI
10.3390/cells8111430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies
- (2019) Xue-Ning Shen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Inflammatory biomarkers in Alzheimer's disease plasma
- (2019) Angharad R. Morgan et al. Alzheimers & Dementia
- Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
- (2019) Anna Rita Zuena et al. Frontiers in Pharmacology
- The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system
- (2019) Daniela Maftei et al. NEUROPHARMACOLOGY
- Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis
- (2018) Sirwan K.L. Darweesh et al. Alzheimers & Dementia
- Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer’s Disease
- (2018) Tommaso Schirinzi et al. JOURNAL OF ALZHEIMERS DISEASE
- The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis
- (2018) Lucia Negri et al. PHYSIOLOGICAL REVIEWS
- Bindarit, Inhibitor of CCL2 Synthesis, Protects Neurons Against Amyloid-β-Induced Toxicity
- (2018) Cinzia Severini et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer’s Disease
- (2017) Akio Kimura et al. JOURNAL OF ALZHEIMERS DISEASE
- Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease
- (2017) Silvia Caioli et al. NEUROPHARMACOLOGY
- Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
- (2017) Gargi Ganguly et al. Drug Design Development and Therapy
- Peripheral Chemokine Receptors, Their Ligands, Cytokines and Alzheimer's Disease
- (2017) Marcella Reale et al. JOURNAL OF ALZHEIMERS DISEASE
- The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease
- (2016) Lorraine F. Clark et al. ACS Chemical Neuroscience
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro
- (2016) Elisa Landucci et al. NEUROPHARMACOLOGY
- Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
- (2016) Sandro Dá Mesquita et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects
- (2015) Ophélia Le Thuc et al. Annals of the New York Academy of Sciences
- Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ
- (2015) S. Strobel et al. JOURNAL OF NEURAL TRANSMISSION
- Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity
- (2015) Cinzia Severini et al. Scientific Reports
- The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis
- (2014) Gholamreza Azizi et al. American Journal of Alzheimers Disease and Other Dementias
- Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
- (2014) Frederic Brosseron et al. MOLECULAR NEUROBIOLOGY
- Lipid-Core Nanocapsules Improve the Effects of Resveratrol Against Aβ-Induced Neuroinflammation
- (2013) Rudimar L. Frozza et al. Journal of Biomedical Nanotechnology
- Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease
- (2012) Mohamad A. Alsadany et al. American Journal of Alzheimers Disease and Other Dementias
- CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
- (2012) Karin Westin et al. PLoS One
- Prokineticin 2 is an endangering mediator of cerebral ischemic injury
- (2012) M. Y. Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
- (2012) Jose Miguel Rubio-Perez et al. TheScientificWorldJOURNAL
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease
- (2008) Tae-Suk Kim et al. NEUROSCIENCE LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started